4 enrolling by invitation. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Enrolling by invitation 4 |
| Phase 1 | 1 | Enrolling by invitation 1 |
Follow Retinal Degeneration: new trials by email Literature Review of Retinal Degeneration trials Research Report on Retinal Degeneration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| 9-cis Beta-Carotene-Rich Extract of Dunaliella Alga in Retinitis Pigmentosa Patients 9-cis beta-Carotene-rich extract of Dunaliella alga, Placebo Corn Oil - Retinitis Pigmentosa | Phase 1 / Phase 2 | Enrolling by invitation | Sheba Medical Center | 41 | 2026-07-26 | 2026-07-27 |
| A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) AGTC-501 (high dose and standard corticosteroid regimen), AGTC-501 (low dose and standard corticosteroid regimen), AGTC-501 (high dose and modified corticosteroid regimen) - X-Linked Retinitis Pigmentosa | Phase 2 | Enrolling by invitation | Beacon Therapeutics | 24 | 2023-11-14 | 2024-10-30 |
| ORACLE: A Long-term Follow-up Study to Evaluate the Safety of GT005 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration Treated in a Gyroscope-sponsored Antecedent Study GT005 - Age Related Macular Degeneration (AMD) | Phase 2 | Enrolling by invitation | Gyroscope Therapeutics Limited | 225 | 2022-07-12 | 2026-09-28 |
| Long-term Follow-Up Study of RGX-314 and Fellow Eye Substudy RGX-314 - Neovascular Age-related Macular Degeneration, Wet Macular Degeneration | Phase 2 | Enrolling by invitation | AbbVie | 865 | 2019-05-31 | 2024-06-17 |
Anetoderma (1) · Geographic Atrophy (1) · Macular Degeneration (1) · Retinal Diseases (1) · Retinitis Pigmentosa (1) · Wet Macular Degeneration (1)
Eye Diseases (4) · Eye Diseases, Hereditary (3) · Retinal Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Connective Tissue Diseases (1) · Genetic Diseases, Inborn (1) · Macular Degeneration (1) · Retinal Dystrophies (1) · Skin Abnormalities (1) · Skin Diseases (1) · Skin and Connective Tissue Diseases (1)
AbbVie (1) · Beacon Therapeutics (1) · Gyroscope Therapeutics Limited (1) · Sheba Medical Center (1)
United States (3) · Australia (1) · France (1) · Germany (1) · Israel (1) · Spain (1) · United Kingdom (1)